sandramycin and Leukemia-P388

sandramycin has been researched along with Leukemia-P388* in 1 studies

Other Studies

1 other study(ies) available for sandramycin and Leukemia-P388

Article	Year
Sandramycin, a novel antitumor antibiotic produced by a Nocardioides sp. Production, isolation, characterization and biological properties. The Journal of antibiotics, 1989, Volume: 42, Issue:12 A new antitumor antibiotic, sandramycin, was isolated from cultured broth of a Nocardioides sp. (ATCC 39419) and purified by solvent partition and column chromatography. Sandramycin, a new depsipeptide, was moderately active in vitro against Gram-positive organisms and in vivo against leukemia P388 in mice. Topics: Animals; Antibiotics, Antineoplastic; Chemical Phenomena; Chemistry; Gram-Positive Bacteria; Leukemia P388; Mice; Microbial Sensitivity Tests; Nocardiaceae; Peptides, Cyclic; Quinolines	1989

Article

Year

Sandramycin, a novel antitumor antibiotic produced by a Nocardioides sp. Production, isolation, characterization and biological properties.

The Journal of antibiotics, 1989, Volume: 42, Issue:12

A new antitumor antibiotic, sandramycin, was isolated from cultured broth of a Nocardioides sp. (ATCC 39419) and purified by solvent partition and column chromatography. Sandramycin, a new depsipeptide, was moderately active in vitro against Gram-positive organisms and in vivo against leukemia P388 in mice.

Topics: Animals; Antibiotics, Antineoplastic; Chemical Phenomena; Chemistry; Gram-Positive Bacteria; Leukemia P388; Mice; Microbial Sensitivity Tests; Nocardiaceae; Peptides, Cyclic; Quinolines

1989